Perspective Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
AMEX
Perspective Therapeutics, Inc. has issued its 2026 proxy statement detailing the upcoming annual meeting agenda, including director elections and executive compensation votes.
AMEX
Perspective Therapeutics, Inc. announces its 2025 Annual Meeting of Stockholders to be held on May 28, 2025, outlining key proposals for voting.
AMEX
Perspective Therapeutics announces its 2025 Annual Meeting of Stockholders to be held on May 28, 2025, to vote on director elections, auditor ratification, and executive compensation.
AMEX
Perspective Therapeutics, Inc. is holding its 2024 Annual Meeting of Stockholders on May 31, 2024, to vote on the election of directors, a proposed reverse stock split, ratification of the accounting firm, and approval of the equity incentive plan.
AMEX
Perspective Therapeutics is asking stockholders to vote on key proposals including a reverse stock split and an amendment to their equity incentive plan at the upcoming annual meeting.